Supply Chain
When it comes to supply chain management, it isn’t just about moving boxes anymore, said Ed Raeke, director of materials management at Massachusetts General Hospital. Spending trends in 2012 will move toward reducing operating expenses for hospitals by effectively using the analytics and tools offered by GPOs.
For every dollar spent on over-the-counter (OTC) medicines, the U.S. healthcare system saves six to seven dollars, providing $102 billion in value annually, says a new report from the Consumer Healthcare Products Association (CHPA).
Doctors' lack of brand loyalty costs Big Pharma billions of dollars annually because doctors prescribe generics as soon as they become available, says a new survey from marketing solutions firm DoctorDirectory.
The Federal Trade Commission filed a lawsuit Friday seeking to block long-term care pharmacy services company OmniCare Inc.'s hostile takeover attempt of rival PharMerica Corp.
New drugs in three multi-billion dollar categories will help pharmaceutical companies offset patent expirations and will ease pressure on credit rating outlooks, says a new report from Moody's Investors Service.
India's largest drug manufacturer, Ranbaxy Laboratories and its U.S. subsidiary, Ranbaxy Inc., and the U.S. Justice Department, and U.S. Food and Drug Administration have reached an agreement over allegations that the company was selling potentially unsafe drugs in the United States.
UPMC attempts to reduce supply chain expenses by using an electronic data interchange.
Genetic and genomic clinical laboratory testing generates 116,000 U.S. jobs and contributes $16.5 billion annually to the U.S. economy, according to a new report released Thursday by the Battelle Memorial Institute.
The market for stem cell technologies will rise to over $700 million this year, and given some positive trends, could reach over $1 billion, according to healthcare market research publisher Kalorama Information.
The U.S. market for orthopedic biomaterials will grow at an average of just under 7 percent per year, to total approximately $4 billion by 2016, predicts medical technology market research firm Millennium Research Group (MRG).